CancerFax Builds Trusted India-China Pathway for Advanced Cancer Treatment Access
CancerFax is expanding its patient navigation services to help Indian patients access advanced oncology treatments, such as CAR-T cell therapy, in Chinese hospitals. The company aims to provide transparency and medical evaluation for those seeking alternatives to standard cancer therapies.
Why it matters
As medical tourism for specialized cancer treatments grows, companies like CancerFax play a role in bridging the gap between international patients and complex foreign healthcare systems.
CancerFax is strengthening its end-to-end patient navigation support for Indian and international patients exploring advanced oncology treatment options at leading hospitals in China, with an emphasis on hospital-based medical evaluation and responsible access.
NEW DELHI , July 13, 2026 /PRNewswire/ -- As China continues to gain attention for advanced oncology treatments including cancer gene therapy, CAR-T cell therapy, immunotherapy, advanced radiotherapy, and clinical trial programs, CancerFax has strengthened its India–China patient navigation pathway to help eligible patients and families explore these options through responsible medical evaluation and hospital coordination.
Interest among Indian patients and caregivers in advanced cancer treatment options abroad has grown steadily, particularly among those looking beyond standard therapy or seeking additional expert opinions. CancerFax says its focus is to bring structure and transparency to that process, so that patients begin with correct medical evaluation rather than confusion.
CHINA'S EVOLVING ADVANCED ONCOLOGY LANDSCAPE
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in